The Early COVID-19 Treatment Data Project (ECTDP) aims to collect, organize, and publish data on the effects of various treatments applied to patients at the earliest stages of COVID-19. Sadly, public health authorities have failed to perform this basic public health function, but it must be done in order to examine the true effects of medical agents when used optimally, which is most often prior to progression from mild to moderate COVID-19. Clearly antiviral agents should be used early, and only a small number of exceptions such as corticosteroids are optimally used at later stage progressions for nearly all patients.

If you are a physician or administrator with raw data to contribute to this project, please read our protocol and contact us at earlyc19treatmentdata@protonmail.com to learn how you can contribute to this project.

Aside from contributing data, one way to support the ECTDP is to subscribe to the project manager’s Rounding the Earth newsletter.